- Home
- SLS vs SSSS Comparison
SLS vs SSSS Comparison
Compare SLS & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLS | SSSS |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 232.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLS | SSSS |
|---|---|---|
| Price | $3.79 | $9.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $10.13 |
| AVG Volume (30 Days) | ★ 14.1M | 131.0K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 10.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.61 |
| Revenue | N/A | ★ $2,354,933.00 |
| Revenue This Year | N/A | $7,183.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.68 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $4.21 |
| 52 Week High | $5.18 | $10.34 |
Technical Indicators
Market Signals| Indicator | SLS | SSSS |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | 60.32 |
| Support Level | $3.23 | $9.27 |
| Resistance Level | $4.42 | $9.64 |
| Average True Range (ATR) | 0.62 | 0.27 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 46.38 | 95.59 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.